BioCentury | Oct 26, 2015
Company News

Commonwealth Laboratories, Quest Diagnostics sales and marketing update

...bowel syndrome (IBS). Commonwealth will analyze samples at its CLIA-certified lab (see BioCentury, July 13). Commonwealth Laboratories Inc....
BioCentury | Sep 7, 2015
Company News

Commonwealth Laboratories, Valeant Pharmaceuticals deal

...and Canada. Valeant did not disclose financial terms, and Commonwealth did not respond to inquiries. Commonwealth Laboratories Inc....
BioCentury | Jul 13, 2015
Company News

Commonwealth Laboratories sales and marketing update

...LDT) detects antibodies against cytolethal distending toxin B (CdtB) and vinculin (VCL) within 24 hours. Commonwealth Laboratories Inc....
BioCentury | Oct 14, 2013
Company News

Commonwealth Laboratories, Cedars Sinai Medical Center deal

...using hydrogen and methane levels in breath samples. The partners declined to disclose financial details. Commonwealth Laboratories Inc....
Items per page:
1 - 4 of 4
BioCentury | Oct 26, 2015
Company News

Commonwealth Laboratories, Quest Diagnostics sales and marketing update

...bowel syndrome (IBS). Commonwealth will analyze samples at its CLIA-certified lab (see BioCentury, July 13). Commonwealth Laboratories Inc....
BioCentury | Sep 7, 2015
Company News

Commonwealth Laboratories, Valeant Pharmaceuticals deal

...and Canada. Valeant did not disclose financial terms, and Commonwealth did not respond to inquiries. Commonwealth Laboratories Inc....
BioCentury | Jul 13, 2015
Company News

Commonwealth Laboratories sales and marketing update

...LDT) detects antibodies against cytolethal distending toxin B (CdtB) and vinculin (VCL) within 24 hours. Commonwealth Laboratories Inc....
BioCentury | Oct 14, 2013
Company News

Commonwealth Laboratories, Cedars Sinai Medical Center deal

...using hydrogen and methane levels in breath samples. The partners declined to disclose financial details. Commonwealth Laboratories Inc....
Items per page:
1 - 4 of 4